And the winner is....Brian Markison!

Quote

Anonymous

Guest
Congratulations appear to be in order, folks.

NEW YORK, Sept. 10, 2012 /PRNewswire/ -- Avista Capital Partners today announced that Brian A. Markison has joined the firm as a healthcare Industry Executive. Mr. Markison has more than 30 years of experience in the pharmaceuticals sector, most recently as President and Chief Executive Officer of Fougera Pharmaceuticals, a dermatology-focused pharmaceuticals company that was spun off from Nycomed A/S in 2011 and sold to Sandoz, the generics division of Novartis, in July 2012.
 


Anonymous said:
Congratulations appear to be in order, folks.

NEW YORK, Sept. 10, 2012 /PRNewswire/ -- Avista Capital Partners today announced that Brian A. Markison has joined the firm as a healthcare Industry Executive. Mr. Markison has more than 30 years of experience in the pharmaceuticals sector, most recently as President and Chief Executive Officer of Fougera Pharmaceuticals, a dermatology-focused pharmaceuticals company that was spun off from Nycomed A/S in 2011 and sold to Sandoz, the generics division of Novartis, in July 2012.
Click to expand...

Jealous Much?????
 






Hey, this guy didn't do too bad either:

NEW YORK, Sept. 10, 2012 /PRNewswire/ -- Greenhill & Co., Inc. (GHL), a leading independent investment bank, announced today that Jeffrey Wasserstein has joined the Firm in New York to enhance its focus on the pharmaceutical sector.
Mr. Wasserstein has a 20 year history in the pharmaceutical industry in corporate development and commercial operating roles for a series of pharmaceutical companies. Most recently he served as Senior Vice President of Business Development & Strategy at Fougera Pharmaceuticals, which was recently sold to the Sandoz division of Novartis AG.

Ah, the reward for a job well done.
 


Anonymous said:
Hey, this guy didn't do too bad either:

NEW YORK, Sept. 10, 2012 /PRNewswire/ -- Greenhill & Co., Inc. (GHL), a leading independent investment bank, announced today that Jeffrey Wasserstein has joined the Firm in New York to enhance its focus on the pharmaceutical sector.
Mr. Wasserstein has a 20 year history in the pharmaceutical industry in corporate development and commercial operating roles for a series of pharmaceutical companies. Most recently he served as Senior Vice President of Business Development & Strategy at Fougera Pharmaceuticals, which was recently sold to the Sandoz division of Novartis AG.

Ah, the reward for a job well done.
Click to expand...

He never f'd anyone over in the company, unlike his predecessor, who will now be Don's biggest headache.
 








what happened to good old Brian? He ruined th elives of many at King. Great company great culture and he could care less. ALL about the $$$.

Does he still head up Fougera or FOU GETTA BOUT IT?
 














Anonymous said:
Really? How can someone that complains as much as you do "never felt better?" Your full of $hit. Complainers always are. Face it. You lose. Again.
Click to expand...

You don't even know how many people you are talking to. The only loser here is you, a VP who can't help posting on CP. How bizarre is that. You better be careful, when Don finds out, he won't be happy.
 









Write your reply...
Top Bottom
Back
Quote